Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

SNOA

Sonoma Pharmaceuticals Inc.

Last Close
Jun 18 • 04:00PM ET
0.1920
Dollar change
+0.0235
Percentage change
13.95 		%
Held by: VXF Scroll to Statements
Index- P/E- EPS (ttm)-0.72 Insider Own1.46% Shs Outstand15.61M Perf Week-5.42%
Market Cap3.00M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float15.38M Perf Month-18.64%
Income-4.83M PEG- EPS next Q- Inst Own1.05% Short Float3.81% Perf Quarter32.41%
Sales12.73M P/S0.24 EPS this Y- Inst Trans-0.66% Short Ratio0.24 Perf Half Y32.51%
Book/sh0.39 P/B0.49 EPS next Y- ROA-30.89% Short Interest0.59M Perf Year-84.76%
Cash/sh0.20 P/C0.96 EPS next 5Y- ROE-68.51% 52W Range0.12 - 1.25 Perf YTD6.43%
Dividend Est.- P/FCF- EPS past 5Y47.04% ROI-77.68% 52W High-84.64% Beta1.34
Dividend TTM- Quick Ratio2.57 Sales past 5Y-6.55% Gross Margin37.26% 52W Low65.66% ATR (14)0.03
Dividend Ex-Date- Current Ratio3.30 EPS Y/Y TTM52.40% Oper. Margin-36.91% RSI (14)51.08 Volatility18.60% 18.90%
Employees172 Debt/Eq0.10 Sales Y/Y TTM-4.05% Profit Margin-37.97% Recom1.00 Target Price3.25
Option/ShortNo / No LT Debt/Eq0.01 EPS Q/Q75.54% Payout- Rel Volume31.95 Prev Close0.17
Sales Surprise- EPS Surprise- Sales Q/Q14.10% EarningsJun 17 AMC Avg Volume2.46M Price0.19
SMA20-3.16% SMA508.43% SMA200-33.96% Trades Volume78,601,717 Change13.95%
Jun-18-24 07:37AM
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
(InvestorPlace) +13.95%
Jun-17-24 09:52PM
SNOA Stock Earnings: Sonoma Pharmaceuticals Misses Revenue for Q4 2024
(InvestorPlace) -5.76%
05:00PM
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results
(ACCESSWIRE)
May-30-24 07:47AM
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
(InvestorPlace) -21.15%
May-09-24 07:30AM
Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores
(ACCESSWIRE)
Apr-09-24 07:30AM
Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States
(ACCESSWIRE) +6.33%
Apr-04-24 07:30AM
Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections
(ACCESSWIRE)
Mar-28-24 04:01PM
Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences
(ACCESSWIRE) -7.88%
Mar-27-24 07:30AM
Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals
(ACCESSWIRE)
Feb-08-24 04:10PM
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results
(ACCESSWIRE)
Jan-23-24 07:30AM
Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use
(ACCESSWIRE)
Jan-09-24 09:15AM
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonomas Extensive Distributor Network
(Business Wire)
Nov-13-23 04:10PM
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results
(ACCESSWIRE) +11.38%
Nov-03-23 07:30AM
Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference
(ACCESSWIRE) +8.40%
Oct-26-23 09:10AM
Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock
(ACCESSWIRE) -49.83%
Sep-21-23 09:35AM
Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference
(GlobeNewswire)
Aug-15-23 07:30AM
National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced
(ACCESSWIRE)
Aug-10-23 04:15PM
Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results
(ACCESSWIRE)
Aug-03-23 07:30AM
Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board
(ACCESSWIRE)
Jun-22-23 07:30AM
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial Results
(ACCESSWIRE)
Jun-09-23 04:40PM
Sonoma Pharmaceuticals Shares Soar 44% After Introducing New Product
(Investopedia) +44.33% -11.43%
Jun-08-23 04:01PM
Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Union
(ACCESSWIRE) +5.40%
Apr-19-23 01:30PM
Benign Growth For Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Underpins Its Share Price
(Simply Wall St.)
Apr-11-23 07:30AM
Sonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot Care
(ACCESSWIRE)
Mar-28-23 04:15PM
Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI North America Conference in Philadelphia
(ACCESSWIRE) +15.03% -18.03%
Mar-02-23 07:30AM
Sonoma Pharmaceuticals and MicroSafe Group Announce New EPA Claims and Green Seal Certification for Nanocyn(R) Hospital-Grade Disinfectant
(ACCESSWIRE)
Feb-14-23 04:30PM
Sonoma Pharmaceuticals Reports Third Quarter 2023 Financial Results
(ACCESSWIRE)
Jan-31-23 07:30AM
Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea
(ACCESSWIRE)
Jan-25-23 07:30AM
Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Products
(ACCESSWIRE) +40.83%
Jan-04-23 07:30AM
Sonoma Pharmaceuticals Launches Two New Products Expanding Its Line of Office Dispense Products Exclusively for Dermatologists and Medical Spas
(ACCESSWIRE) -6.30%
Nov-17-22 05:33AM
Sonoma Pharmaceuticals Second Quarter 2023 Earnings: US$0.33 loss per share (vs US$0.043 loss in 2Q 2022)
(Simply Wall St.)
Nov-14-22 04:15PM
Sonoma Pharmaceuticals Reports Second Quarter 2023 Financial Results
(ACCESSWIRE) +7.21%
Oct-27-22 04:01PM
Sonoma Pharmaceuticals Launches Two New Dermatological Products for Over-The-Counter Use in the United States
(ACCESSWIRE)
Oct-06-22 04:15PM
Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI Conference in Frankfurt, Germany
(ACCESSWIRE) -8.81%
Aug-11-22 04:30PM
Sonoma Pharmaceuticals Reports First Quarter 2023 Financial Results
(ACCESSWIRE)
Aug-02-22 04:30PM
Sonoma Pharmaceuticals Launches MicrocynVS(R) Line of Products Exclusively for Veterinarian Use and Announces Partnership with DV Medical Supply
(ACCESSWIRE) +7.96%
Jul-13-22 04:45PM
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results
(ACCESSWIRE)
Jun-01-22 06:00AM
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce that U.S. EPA has Added Nanocyn® Hospital-Grade Disinfectant to List N for Use Against COVID-19
(Business Wire) -11.59%
May-03-22 06:00AM
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the U.S.
(Business Wire) +31.55%
Mar-30-22 11:20AM
Sonoma Pharma Launches New Urinary Tract Infection Product In New Zealand, Australia, South Africa
(Benzinga) +13.39%
06:00AM
Sonoma Pharmaceuticals Launches New Urinary Tract Infection Product Through Distributors in New Zealand, Australia and South Africa
(Business Wire)
Feb-11-22 04:30PM
Sonoma Pharmaceuticals Reports Third Quarter FY 2022 Financial Results
(Business Wire) -6.90%
Jan-28-22 09:38AM
HBC Financial Services, PLLC Buys Apollo Investment Corp, Lockheed Martin Corp, Airbnb Inc, ...
(GuruFocus.com)
Jan-20-22 04:40PM
Sonoma Pharmaceuticals Announces Expansion of its Partner Network for Oral and Dental Products in the U.S. and China
(Business Wire) -10.35%
Jan-05-22 04:55PM
Sonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13, 2022
(Business Wire)
Nov-15-21 08:00AM
Sonoma Pharmaceuticals Reports Second Quarter FY 2022 Financial Results
(Business Wire)
Nov-09-21 07:00AM
Sonoma Pharmaceuticals and Dyamed Biotech Announce Expanded Long-Term Partnership for New Territories and Products in Southeast Asia
(Business Wire)
Oct-15-21 07:44AM
The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO
(Benzinga) +5.56%
07:00AM
Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn® Disinfectant & Sanitizer Has Been Approved by the Australia TGA with a 15 Second SARS-CoV-2 (COVID-19) Kill Time
(Business Wire)
Sep-30-21 12:50PM
Sonoma Pharmaceuticals (NASDAQ:SNOA) Has Debt But No Earnings; Should You Worry?
(Simply Wall St.) -9.27%
Sep-29-21 03:37AM
48 Biggest Movers From Yesterday
(Benzinga) -12.02%
Sep-28-21 02:37PM
Mid-Afternoon Market Update: Dow Tumbles 500 Points; Sonoma Pharmaceuticals Shares Spike Higher
(Benzinga) +30.65%
12:05PM
Mid-Day Market Update: Nasdaq Down 2.5%; IHS Markit Posts Upbeat Earnings
(Benzinga)
07:00AM
Sonoma Pharmaceuticals Launches Its First Over-the-Counter Products in the U.S. on Amazon and a New Consumer-Focused Product on Amazon in Europe
(Business Wire)
Aug-20-21 12:19PM
Why Sonoma Pharmaceuticals Shares Are Trading Lower Today
(Benzinga) -23.93%
Aug-19-21 01:19PM
Why Sonoma Pharmaceuticals Shares Are Surging Higher Today
(Benzinga) +50.65%
09:46AM
Why Sonoma Pharma (SNOA) Stock Skyrocketing On Thursday
(Benzinga)
08:23AM
5 Top Stock Gainers for Thursday: Macy's, Nvidia, Sonoma Pharma and Kohl's
(TheStreet.com)
07:00AM
Sonoma Pharmaceuticals Announces Expanded Dental Care Line with a New Product for Professional Care in the U.S. and a New Product for Professional and Consumer Care in Switzerland
(Business Wire)
06:44AM
Sonoma Pharma Stock Doubles on New Dental Products Launch
(TheStreet.com)
Aug-16-21 04:15PM
Sonoma Pharmaceuticals Reports First Quarter 2022 Financial Results
(Business Wire) -6.47%
Jul-15-21 03:51PM
Why Sonoma Pharmaceuticals Shares Are Getting Hammered Today
(Benzinga) -17.06%
Jul-14-21 07:56PM
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2021 Financial Results
(Business Wire) -13.61%
Mar-31-21 04:10PM
Sonoma Pharmaceuticals and EMC Pharma Announce an Exclusive Partnership to Expand Commercial Channels of the Microcyn®-based Rx Dermatology and Eye Care Products Nationwide
(Business Wire) +8.47% +18.44%
Mar-11-21 09:00PM
SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm
(Business Wire)
Mar-09-21 08:15PM
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Sonoma Pharmaceuticals, Inc. Investors with Losses to Inquire About Securities Class Action Investigation SNOA
(Business Wire) +5.45%
Mar-04-21 05:03PM
Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences
(Business Wire) -13.80%
Feb-19-21 05:07PM
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Sonoma Pharmaceuticals, Inc. Investors with Losses to Inquire About Securities Class Action Investigation - SNOA
(Newsfile) -5.27%
Feb-16-21 05:30PM
Sonoma Pharmaceuticals Reports Third Quarter FY 2021 Financial Results
(Business Wire) +5.13%
Feb-15-21 03:45PM
BREAKING ALERT: ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Sonoma Pharmaceuticals, Inc. Investors with Losses to Inquire About Securities Class Action Investigation SNOA
(GlobeNewswire)
Feb-10-21 12:50PM
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sonoma Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
(ACCESSWIRE)
Feb-08-21 11:07AM
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Sonoma Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
(Newsfile)
Feb-02-21 08:00AM
Sonoma Pharmaceuticals, Inc.: Company Investigated by the Portnoy Law Firm
(GlobeNewswire)
Feb-01-21 03:47PM
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Sonoma Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
(PR Newswire)
Jan-28-21 04:30PM
Sonoma Pharmaceuticals and Microderm Technologies Announce that Dermodacyn® Disinfecting Solution is Now Available in Hong Kong and Thailand
(Business Wire) +9.62% -7.99%
Jan-27-21 02:30PM
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sonoma Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
(ACCESSWIRE)
Jan-18-21 06:00PM
ROSEN, GLOBAL INVESTOR COUNSEL, Continues To Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. - SNOA
(PR Newswire)
Jan-14-21 11:45AM
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Sonoma Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
(ACCESSWIRE)
Jan-11-21 05:30PM
Sonoma Pharmaceuticals to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference
(Business Wire) +6.20%
Dec-24-20 04:07PM
ROSEN, A LEADING INVESTOR FIRM, Continues To Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. SNOA
(Business Wire)
Dec-23-20 12:40AM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sonoma Pharmaceuticals, Inc. - SNOA
(ACCESSWIRE)
Dec-19-20 11:35PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sonoma Pharmaceuticals, Inc. - SNOA
(GlobeNewswire)
Dec-17-20 06:17PM
ROSEN, RESPECTED INVESTOR COUNSEL, Continues Its Investigation of Securities Claims Against Sonoma Pharmaceuticals, Inc. SNOA
(GlobeNewswire) -5.80% +19.00%
04:10PM
Sonoma Pharmaceuticals Announces Partnership with Gabriel Science, LLC For Dental Markets
(Business Wire)
Dec-16-20 04:47PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sonoma Pharmaceuticals, Inc. - SNOA
(Newsfile)
Dec-12-20 08:08PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sonoma Pharmaceuticals, Inc. - SNOA
(GlobeNewswire)
Dec-11-20 10:37AM
Sonoma Pharmaceuticals News Alert: Why SNOA Stock Is Rocketing Higher Today
(InvestorPlace) +42.90%
08:11AM
The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street
(Benzinga)
Dec-10-20 04:10PM
Sonoma Pharmaceuticals and Crown Laboratories Announce an Exclusive Partnership to Launch Microcyn® Technology-Based Anti-Itch Over-the-Counter Products
(Business Wire)
Dec-09-20 11:30PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sonoma Pharmaceuticals, Inc. - SNOA
(ACCESSWIRE)
Dec-08-20 03:47PM
ROSEN, GLOBAL INVESTOR COUNSEL, Continues Its Investigation of Securities Claims Against Sonoma Pharmaceuticals, Inc. - SNOA
(Newsfile)
Dec-07-20 08:13PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sonoma Pharmaceuticals, Inc. - SNOA
(GlobeNewswire)
Dec-05-20 09:20PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sonoma Pharmaceuticals, Inc. - SNOA
(ACCESSWIRE)
Dec-02-20 02:15PM
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sonoma Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
(ACCESSWIRE)
09:25AM
ROSEN, RESPECTED INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. SNOA
(GlobeNewswire)
Dec-01-20 01:15PM
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Sonoma Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
(ACCESSWIRE)
Nov-30-20 09:00PM
SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm
(GlobeNewswire)
08:46PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sonoma Pharmaceuticals, Inc.  SNOA
(GlobeNewswire)
Nov-29-20 07:45AM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sonoma Pharmaceuticals, Inc. - SNOA
(ACCESSWIRE)
Nov-27-20 10:17AM
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sonoma Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
(Business Wire)
Sonoma Pharmaceuticals, Inc. engages in the development and production of hypochlorous acid (HOCl) products for wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Boulder, CO.
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • careers • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.